Dear All,

Please find the material that we will be referring to in order to address potential harms of Closed Generics.

Kind regards,

Michael Flemming


On Mon, Apr 10, 2017 at 6:28 PM, Michael Flemming <flemming@brightsconsulting.com> wrote:
Dear All,

This week on 13 April 2017 at 21 UTC we will be once again discussing Closed Generics. As of our last meeting, we went through the Pros and Cons of Closed Generics by looking at the comments made in the Public Comments. We have not reached a consensus on anything at this point, however, we have not had a lot of input for the Cons and potential harm of Closed Generics at the current time. This week we will try to distinguish what potential harm exists if Closed Generics were allowed by analyzing the Public Comments even further. I welcome anyone who would like to assist in this discussion and analysis by joining us this week. Below is the agenda.

  1. Welcome

  2. SOI

  3. Closed Generics

  4. AOB

I look forward to speaking with everyone and having an exciting conversation!

Kind regards,

Michael Flemming